Tarsus Pharmaceuticals (TARS) Change in Receivables (2021 - 2026)
Tarsus Pharmaceuticals' Change in Receivables was $4.41 million in Q3 2026, down 69.2% from $14.29 million a year earlier.
Powered by 
Analysis
Tarsus Pharmaceuticals (TARS) Change in Receivables (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Tarsus Pharmaceuticals' Change in Receivables was $27.82 million through Sep 30, 2026, down 36.0% year-over-year; for FY2025, it was $38.3 million, up 27.1% from FY2024.
- In earlier years, Change in Receivables was $30.14 million in FY2024 (+81.3%) and $16.62 million in FY2023.
- Quarterly Change in Receivables has moved between -$19.32 million (Q2 2026) and $30.29 million (Q1 2026) over five years.
- Compared with a year earlier, Change in Receivables was higher in three of the last five quarters, with growth averaging 13.9%.
- Per Business Quant data, TARS's Change in Receivables in the three quarters before Q3 2026 was -$19.32 million (Q2 2026), $30.29 million (Q1 2026) and $12.44 million (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,264.65 Bn | 1,238.27 Bn | 20.46 Bn | - |
| 2 | Johnson & Johnson | 677.74 Bn | 597.60 Bn | 17.30 Bn | -188.00 Mn |
| 3 | AbbVie | 517.10 Bn | 485.11 Bn | 13.12 Bn | -312.00 Mn |
| 4 | Merck | 362.23 Bn | 325.17 Bn | 13.19 Bn | - |
| 5 | Novartis Ag | 315.90 Bn | 276.16 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 289.40 Bn | 266.24 Bn | 12.86 Bn | - |
| 7 | Amgen | 249.90 Bn | 201.56 Bn | 7.58 Bn | 108.00 Mn |
| 8 | Gilead Sciences | 209.15 Bn | 184.26 Bn | 6.73 Bn | -52.00 Mn |
| 9 | Pfizer | 165.88 Bn | 113.23 Bn | 12.56 Bn | - |
| 10 | Tarsus Pharmaceuticals | 3.35 Bn | 2.41 Bn | 180.68 Mn | 4.41 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 4.41 Mn |
| Jun 30, 2026 | -19.32 Mn |
| Mar 31, 2026 | 30.29 Mn |
| Dec 31, 2025 | 12.44 Mn |
| Sep 30, 2025 | 14.29 Mn |
| Jun 30, 2025 | -4.09 Mn |
| Mar 31, 2025 | 15.67 Mn |
| Dec 31, 2024 | 17.60 Mn |
| Sep 30, 2024 | -370,000.00 |
| Jun 30, 2024 | -356,000.00 |
| Mar 31, 2024 | 13.26 Mn |
| Dec 31, 2023 | 11.26 Mn |
| Sep 30, 2023 | 5.36 Mn |
| Jun 30, 2023 | -2.50 Mn |
| Mar 31, 2023 | 2.50 Mn |
| Dec 31, 2022 | -17,000.00 |
| Mar 31, 2022 | 17,000.00 |
| Sep 30, 2021 | -20.00 Mn |
| Jun 30, 2021 | -5.00 Mn |
| Mar 31, 2021 | 25.00 Mn |
API Access
Tarsus Pharmaceuticals Change in Receivables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=change-in-receivables&ticker=TARS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "change-in-receivables", "ticker": "TARS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=change-in-receivables&ticker=TARS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();